Pütsep et al. showed that G-CSF-treated SCN3 patients have proper numbers of circulating neutrophils but that these cells have an impaired production of the antimicrobial peptide cathelicidin LL-37 and its precursor (71). This evidence concerns the gene CAMP and Kostmann syndrome.